Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$351M |
| 2 |
Netflix
NFLX
|
+$343M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$293M |
| 4 |
Nike
NKE
|
+$186M |
| 5 |
Delta Air Lines
DAL
|
+$177M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$1.33B |
| 2 |
Tesla
TSLA
|
+$344M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$306M |
| 4 |
NVIDIA
NVDA
|
+$281M |
| 5 |
Boeing
BA
|
+$251M |
Sector Composition
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.45% |
| 3 | Consumer Discretionary | 12.35% |
| 4 | Consumer Staples | 10.15% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QXO
3251
QXO Inc
QXO
$14.5B
| $99K | ﹤0.01% |
3,783
+395
| +12% | +$10.3K |
|
|
STEC
3252
Santech Holdings Limited American Depositary Shares
STEC
$178M
| $99K | ﹤0.01% |
13,800
+200
| +1% | +$1.44K |
|
|
CLVR
3253
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
| $98K | ﹤0.01% |
28,489
+4,901
| +21% | +$16.9K |
|
3254
Werewolf Therapeutics
HOWL
$64.5M
| $97K | ﹤0.01% |
45,200
+2,300
| +5% | +$4.94K |
|
3255
Allogene Therapeutics
ALLO
$246M
| $96K | ﹤0.01% |
30,282
-221,618
| -88% | -$703K |
|
3256
ASP Isotopes
ASPI
$769M
| $96K | ﹤0.01% |
100,879
-378,121
| -79% | -$360K |
|
3257
8x8 Inc
EGHT
$285M
| $96K | ﹤0.01% |
38,030
-285,758
| -88% | -$721K |
|
3258
Achieve Life Sciences
ACHV
$168M
| $95K | ﹤0.01% |
22,100
-17,500
| -44% | -$75.2K |
|
3259
Laird Superfood
LSF
$62.3M
| $95K | ﹤0.01% |
92,200
+2,100
| +2% | +$2.16K |
|
3260
Pluri
PLUR
$37.3M
| $95K | ﹤0.01% |
19,738
+6,588
| +50% | +$31.7K |
|
3261
Zenvia
ZENV
$69.7M
| $95K | ﹤0.01% |
90,200
+41,000
| +83% | +$43.2K |
|
3262
Fortress Biotech
FBIO
$114M
| $94K | ﹤0.01% |
21,575
+6,347
| +42% | +$27.7K |
|
|
ONCT
3263
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $94K | ﹤0.01% |
15,665
+1,315
| +9% | +$7.89K |
|
|
RVLP
3264
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $93K | ﹤0.01% |
1,079,515
+384,600
| +55% | +$33.1K |
|
3265
a.k.a. Brands
AKA
$114M
| $93K | ﹤0.01% |
17,875
-19,125
| -52% | -$99.5K |
|
3266
Enlivex Therapeutics
ENLV
$24.2M
| $93K | ﹤0.01% |
58,889
+2,200
| +4% | +$3.47K |
|
|
VBNK
3267
VersaBank
VBNK
$391M
| $93K | ﹤0.01% |
+11,900
| New | +$93K |
|
|
UBX
3268
DELISTED
Unity Biotechnology
UBX
| $92K | ﹤0.01% |
38,371
-4,100
| -10% | -$9.83K |
|
|
CBD
3269
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $92K | ﹤0.01% |
137,900
-15,200
| -10% | -$10.1K |
|
3270
Dominari Holdings
DOMH
$103M
| $91K | ﹤0.01% |
39,326
+2,000
| +5% | +$4.63K |
|
3271
Mustang Bio
MBIO
$10.2M
| $91K | ﹤0.01% |
884
-4
| -0.5% | -$412 |
|
|
ZFOX
3272
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
| $90K | ﹤0.01% |
101,970
-24,430
| -19% | -$21.6K |
|
|
BCEL
3273
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $89K | ﹤0.01% |
341,924
+26,300
| +8% | +$6.85K |
|
|
PHX
3274
DELISTED
PHX Minerals
PHX
| $89K | ﹤0.01% |
24,392
-85,640
| -78% | -$312K |
|
3275
Vasta Platform
VSTA
$369M
| $89K | ﹤0.01% |
21,500
+1,200
| +6% | +$4.97K |
|